Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

 Pursuant to Regulation 82(4) of Securities and Exchange Board of India (Issue of Capital and Disclosure Requirement) Regulations, 2018 and Regulation 32 (6) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing herewith the Monitoring Agency Report regarding utilization of proceeds of the Rights Issue of the Company for the quarter ended on March 31, 2023, issued by CRISIL Ratings Limited, Monitoring Agency.
12-05-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, please find enclosed the copies of the newspaper advertisement regarding Audited Financial Results of the Company for quarter and year ended 31st March, 2023. The advertisements are as appeared on 10th May, 2023 in Business Standard and Andhra Prabha (Telugu). The above information will also be hosted on the website of the Company at www.suven.com/newspaperads.aspx.
10-05-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Related Party Transactions And Balances For The Half Year Ended March 31St, 2023

 Pursuant to Regulation 23(9) of Listing Regulations, please find enclosed disclosure of Related Party Transactions and balances for the half year ended March 31st, 2023
09-05-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Statement Of Deviation(S) Or Variation(S) For Quarter Ended 31St March, 2023 Under Regulation 32 Of SEBI (LODR) Regulations, 2015

 With reference to the above subject, please find enclosed statement confirming that there were no deviation(s) or variation(s) in the use of proceeds, from the objects for which funds were raised through the preferential issue made by the Company, for the quarter ended 31st March, 2023
09-05-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Closure Of Register Of Members For The Purpose Of 34Th Annual General Meeting Of The Company

 Pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Member and Share Transfer Books of the Company will remain closed from 03rd August, 2023 to 05th August, 2023 (both days inclusive) for taking record of the Members of the Company for the purpose of 34th Annual General Meeting of the Company.
09-05-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Reappointment Of Independent Directors

 We wish to inform you that based on the recommendation of Nomination and Remuneration Committee, the Board of Directors at its meeting held today i.e. May 09, 2023 has approved the re-appointment of Shri Santanu Mukherjee (DIN: 07716452) and Smt. Ananthasai Padmaja Jasthi (DIN: 07484630) as Independent Directors of the Company for the second term of 5 years.
09-05-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Outcome for Outcome Of The Board Meeting

 With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. May 09, 2023, approved the following along with other business matters. 1) Took on record and approved the Audited Standalone and Consolidated Financial Results prepared under Ind AS for the quarter and Financial Year ended 31st March, 2023 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Audit Reports of the Statutory Auditors. 2) Re-appointment of Independent Directors 3) Closure of Register of Members & Share Transfer Books 4) e-Annual General Meeting (AGM)
09-05-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Audited Standalone And Consolidated Financial Results Prepared Under Ind AS For The Quarter And Financial Year Ended 31St March, 2023

 With reference to the above subject, the Board of Directors of the company, at its meeting held today i.e. May 09, 2023, approved the following along with other business matters. Took on record and approved the Audited Standalone and Consolidated Financial Results prepared under Ind AS for the quarter and Financial Year ended 31st March, 2023 pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 along with Audit Reports of the Statutory Auditors.
09-05-2023
Bigul

Annual report for Suven Life Sciences Ltd. for FY-2023
09-05-2023
Bigul

SUVEN LIFE SCIENCES LTD. - 530239 - Board Meeting Intimation for Audited Financial Results (Standalone And Consolidated) Of The Company Under Ind AS For The Fourth Quarter And Year Ended 31St March, 2023 And Other Matters

 SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/05/2023 ,inter alia, to consider and approve With reference to above subject, pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that a Meeting of the Board of Directors of the Company will be held on Tuesday, the 09th May, 2023 at 11:30 a.m. at the Registered Office of the Company at SDE Serene Chambers, 6th Floor, Road No 5, Banjara Hills, Hyderabad-500034, to consider, among other things, inter alia, and take on record the following matter(s): To consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the fourth quarter and year ended 31st March, 2023 and related matters.
02-05-2023
Next Page
Close

Let's Open Free Demat Account